Ellsworth Advisors »

Centessa Pharmaceuticals shares owned by Ellsworth Advisors

Quarter-by-quarter ownership of Centessa Pharmaceuticals (CNTA) shares owned by Ellsworth Advisors from 13F filings

Historical chart of Ellsworth Advisors investment in Centessa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Centessa Pharmaceuticals held by Ellsworth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Centessa Pharmaceuticals by Ellsworth Advisors

Quarter filed Position value Share count Share price at filing
2025-03-31 $703k 49k 14.38

More positions owned by Ellsworth Advisors

Spdr Gold Tr Gold Shs (GLD)
NVIDIA Corporation (NVDA)
Harbor Etf Trust Harbor Commodity (HGER)
First Tr Exchange-traded First Tr Enh New (FTSM)
Apple (AAPL)
Alphabet Cap Stk Cl C (GOOG)
Johnson & Johnson (JNJ)
Amgen (AMGN)
Advanced Micro Devices (AMD)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Anglogold Ashanti Com Shs (AU)
Cisco Systems (CSCO)
Packaging Corporation of America (PKG)
Darden Restaurants (DRI)

View all positions for Ellsworth Advisors

Top funds holding Centessa Pharmaceuticals

Medicxi Ventures Management
venBio Select Advisor
Adage Capital Partners GP
General Atlantic
FMR
Henderson Group
Farallon Capital Management
First Light Asset Management
Siren
TCG Crossover Management
Perceptive Advisors
Commodore Capital
Franklin Resources
Rtw Investments
Cormorant Asset Management

View all funds holding Centessa Pharmaceuticals